Switching to tenofovir alafenamide in patients with virologically suppressed chronic hepatitis B and renal or hepatic impairment: final week 96 result
- Lancet Gastroenterol. Hepatol. Jun 17 2024, S2468-1253(24)00096-7 | https://doi.org/10.1016/S2468-1253(24)00096-7